Expression of neural markers on bone marrow–derived canine mesenchymal stem cells
- 1 November 2006
- journal article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 67 (11), 1921-1928
- https://doi.org/10.2460/ajvr.67.11.1921
Abstract
Objective—To evaluate cell surface markers of bone marrow–derived canine mesenchymal stem cells (MSCs) by use of flow cytometric analysis and determine whether canine MSCs express proteins specific to neuronal and glial cells. Sample Population—Bone marrow aspirates collected from iliac crests of 5 cadavers of young adult dogs. Procedures—Flow cytometric analysis was performed to evaluate cell surface markers and homogeneity of third-passage MSCs. Neural differentiation of canine MSCs was induced by use of dibutyryl cAMP and methyl-isobutylxanthine. Expressions of neuronal (β III-tubulin) and glial (glial fibrillary acidic protein [GFAP] and myelin basic protein) proteins were evaluated by use of immunocytochemical and western blot analyses before and after neural differentiation. Results—Third-passage canine MSCs appeared morphologically homogeneous and shared phenotypic characteristics with human and rodent MSCs. Immunocytochemical and western blot analyses revealed that canine MSCs constitutively expressed β III-tubulin and GFAP. After induction of neural differentiation, increased expression of GFAP was found in all samples, whereas such change was inconsistent in β III-tubulin expression. Myelin basic protein remained undetectable on canine MSCs for these culture conditions. Conclusions and Clinical Relevance—Canine bone marrow–derived mononuclear cells yielded an apparently homogeneous population of MSCs after expansion in culture. Expanded canine MSCs constitutively expressed neuron or astrocyte specific proteins. Furthermore, increases of intracellular cAMP concentrations induced increased expression of GFAP on canine MSCs, which suggests that these cells may have the capacity to respond to external signals. Canine MSCs may hold therapeutic potential for treatment of dogs with neurologic disorders.Keywords
This publication has 50 references indexed in Scilit:
- Cytokine‐induced stable neuronal differentiation of human bone marrow mesenchymal stem cells in a serum/feeder cell‐free conditionDevelopment, Growth & Differentiation, 2005
- Treatment of neurodegenerative diseases using adult bone marrow stromal cell-derived neuronsExpert Opinion on Biological Therapy, 2005
- T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppressionJournal of Biomedical Science, 2005
- Generation of purified oligodendrocyte progenitors from embryonic stem cellsThe FASEB Journal, 2004
- Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formationExperimental Neurology, 2004
- Migration and differentiation of nuclear fluorescence‐labeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in miceNeuropathology, 2003
- Pluripotency of mesenchymal stem cells derived from adult marrowNature, 2002
- In vitro differentiation of transplantable neural precursors from human embryonic stem cellsNature Biotechnology, 2001
- Adult rat and human bone marrow stromal cells differentiate into neuronsJournal of Neuroscience Research, 2000
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999